Size | Price | |
---|---|---|
500mg | ||
1g | ||
Other Sizes |
ln Vitro |
cis-Vaccenic acid (CVA) at concentrations of 50 μM, 70 μM, and 100 μM stimulates the production of gamma globin and causes differentiation in K562, JK1, and transgenic mouse erythroid progenitor stem cells[2]. Additionally, the proportion of JK-1 cells positive for benzidine was raised by 50 μM of cis-Vaccenic acid[2]. cis-Vaccenic acid
|
---|---|
Cell Assay |
Cell Differentiation Assay[2]
Cell Types: K562 cells Tested Concentrations: 50 μM, 70 μM and 100 μM Incubation Duration: 48 and 120 hrs (hours) Experimental Results: Induced differentiation appeared to be concentration dependent in K562 cells with 50 μM CVA being the most effective concentration with more than 20% of the K562 cells showing positive for Benzidine stain after 48 h of incubation with CVA. |
References |
|
Additional Infomation |
Cis-vaccenic acid is the cis isomer of vaccenic acid. It is a conjugate acid of a cis-vaccenate(1-).
Vaccenic acid is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). cis-Vaccenic acid has been reported in Agaricus blazei, Phormidium tenue, and other organisms with data available. See also: Cod Liver Oil (part of); Krill oil (part of); Oleic Acid (annotation moved to). |
Molecular Formula |
C18H34O2
|
---|---|
Exact Mass |
282.255
|
CAS # |
506-17-2
|
Related CAS # |
trans-Vaccenic acid;693-72-1;cis-Vaccenic acid-d13
|
PubChem CID |
5282761
|
Appearance |
Colorless to light yellow liquid
|
Density |
0.9±0.1 g/cm3
|
Boiling Point |
398.2±11.0 °C at 760 mmHg
|
Melting Point |
14-15ºC(lit.)
|
Flash Point |
295.0±14.4 °C
|
Vapour Pressure |
0.0±2.0 mmHg at 25°C
|
Index of Refraction |
1.467
|
LogP |
7.7
|
Hydrogen Bond Donor Count |
1
|
Hydrogen Bond Acceptor Count |
2
|
Rotatable Bond Count |
15
|
Heavy Atom Count |
20
|
Complexity |
234
|
Defined Atom Stereocenter Count |
0
|
SMILES |
CCCCCC/C=C\CCCCCCCCCC(=O)O
|
InChi Key |
UWHZIFQPPBDJPM-FPLPWBNLSA-N
|
InChi Code |
InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-8H,2-6,9-17H2,1H3,(H,19,20)/b8-7-
|
Chemical Name |
(Z)-octadec-11-enoic acid
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : ≥ 50 mg/mL (177.02 mM)
|
---|---|
Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.